Indication

Hormone receptor positive postmenopausal advanced breast cancer

Hormone receptor-positive postmenopausal advanced breast cancer refers to locally advanced or metastatic malignancy arising from breast tissue in females who have experienced the permanent cessation of ovarian function. Read more about Hormone receptor positive postmenopausal advanced breast cancer

73 drugs 56 manufacturers

Advertisement

Drugs that treat it

Common Hormone receptor positive postmenopausal advanced breast cancer therapies.

Showing 55–63 of 73 drugs

ANASTROZOLE

AROMATASE INHIBITORS·METASTATIC BREAST CARCINOMA·+2
AUROBINDO PHARM

FULVESTRANT

ANTIESTROGEN·HORMONE RECEPTOR POSITIVE POSTMENOPAUSAL ADVANCED BREAST CANCER·+1
BLUEPOINT LABOR

FULVESTRANT

ANTIESTROGEN·HORMONE RECEPTOR POSITIVE POSTMENOPAUSAL ADVANCED BREAST CANCER·+1
ZYDUS PHARMACEU

FULVESTRANT

ANTIESTROGEN·HORMONE RECEPTOR POSITIVE POSTMENOPAUSAL ADVANCED BREAST CANCER·+1
ATHENEX PHARMAC

FULVESTRANT

ANTIESTROGEN·HORMONE RECEPTOR POSITIVE POSTMENOPAUSAL ADVANCED BREAST CANCER·+1
AVENACY, INC

ANASTROZOLE

AROMATASE INHIBITORS·METASTATIC BREAST CARCINOMA·+2
PD-RX PHARM

FULVESTRANT

ANTIESTROGEN·HORMONE RECEPTOR POSITIVE POSTMENOPAUSAL ADVANCED BREAST CANCER·+1
BLUEPOINT/ONCOP

FULVESTRANT

ANTIESTROGEN·HORMONE RECEPTOR POSITIVE POSTMENOPAUSAL ADVANCED BREAST CANCER·+1
XIROMED, LLC

ANASTROZOLE

AROMATASE INHIBITORS·METASTATIC BREAST CARCINOMA·+2
Avet Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Hormone receptor positive postmenopausal advanced breast cancer preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hormone receptor positive postmenopausal advanced breast cancer.

Hormone receptor-positive postmenopausal advanced breast cancer refers to locally advanced or metastatic malignancy arising from breast tissue in females who have experienced the permanent cessation of ovarian function.

Pathophysiologically, the tumor cells express estrogen receptors, progesterone receptors, or both, rendering disease proliferation dependent on estrogenic signaling pathways derived primarily from peripheral aromatization in postmenopausal biology.

The advanced stage signifies that the neoplasm is unresectable, involves extensive regional lymph nodes or chest wall structures, or has disseminated hematogenously to distant metastatic sites such as bone, liver, lungs, or brain.

Personalize your experience

Follow Hormone receptor positive postmenopausal advanced breast cancer and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it